Evidence map›Paper›PMID 31081577›Full record

ReviewJournal of internal medicine2019

The Circadian Syndrome: is the Metabolic Syndrome and much more!

P Zimmet, K G M M Alberti, N Stern, C Bilu, A El-Osta, H Einat, N Kronfeld-Schor

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 2 syntheses or guidelines pooled it, 358 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. The British journal of nutrition · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

P ZimmetDepartment of Diabetes, Central Clinical School, Monash University, Melbourne, Vic., Australia.
K G M M AlbertiImperial College, London, UK.
N SternSagol Center for Epigenetics and Metabolism, Tel Aviv Medical Center, Tel Aviv, Israel.
C BiluSchool of Zoology, Tel Aviv University, Tel Aviv, Israel.
A El-OstaDepartment of Diabetes, Central Clinical School, Monash University, Melbourne, Vic., Australia.
H EinatSchool of Behavioral Sciences, Tel Aviv-Yaffo Academic College, Tel Aviv, Israel.
N Kronfeld-SchorSchool of Zoology, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-5224-3341
Tel Aviv University · ILAcademic College of Tel Aviv-Yafo · ILImperial College London · GBThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Metabolic Syndrome is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. It is responsible for huge socio-economic costs with its resulting morbidity and mortality in most countries. The underlying aetiology of this clustering has been the subject of much debate. More recently, significant interest has focussed on the involvement of the circadian system, a major regulator of almost every aspect of human health and metabolism. The Circadian Syndrome has now been implicated in several chronic diseases including type 2 diabetes and cardiovascular disease. There is now increasing evidence connecting disturbances in circadian rhythm with not only the key components of the Metabolic Syndrome but also its main comorbidities including sleep disturbances, depression, steatohepatitis and cognitive dysfunction. Based on this, we now propose that circadian disruption may be an important underlying aetiological factor for the Metabolic Syndrome and we suggest that it be renamed the 'Circadian Syndrome'. With the increased recognition of the 'Circadian Syndrome', circadian medicine, through the timing of exercise, light exposure, food consumption, dispensing of medications and sleep, is likely to play a much greater role in the maintenance of both individual and population health in the future.

Indexed as

Circadian RhythmCognition DisordersDepressionFatty LiverHumansLife StyleMetabolic SyndromeRisk FactorsSleep Disorders, Circadian Rhythmcircadian clockdiabetesmetabolic syndrome

Identifiers

PMID31081577
PMCPMC6851668
OpenAlexW2946781915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.